C
EW icon

Certuity’s Edwards Lifesciences EW Stock Holding History

Certuity’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,400
Closed -$186K – 194
2019
Q4 		$186K Buy
+2,400
New +$187K 0.09% 169

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Certuity's EW Position: Q1 2026 in Review

Certuity increased its Edwards Lifesciences (EW) stake by 38% in Q1 2026, buying an estimated $73.7K and bringing the position to 3,247 shares worth $260K. The position accounts for 0.02% of the portfolio, ranked #511.

Certuity first reported a position in EW in Q4 2019 and has held it in 14 quarters since. The position peaked at $351K in Q1 2022. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Certuity held 3,247 shares of Edwards Lifesciences worth $260K as of Q1 2026.
  • Certuity bought 894 Edwards Lifesciences shares in Q1 2026, an estimated $73.7K.
  • Edwards Lifesciences made up 0.02% of Certuity's portfolio in Q1 2026, its #511 holding.
  • Certuity first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 14 quarters since.
  • Certuity's Edwards Lifesciences position peaked at $351K in Q1 2022.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Certuity's 13F filing for Q1 2026, filed 11 May 2026.